The Lowdown on Cancer focuses on the impact of cancer on lives and on the things that give us hope. From the pain of learning you have cancer to innovative new treatments offered by the best and brightest, we’ll give you the Lowdown.
Yes, cancer sucks. But you are not alone. And we are not without hope!
Dr. Chalasani has a resume of achievements so long that just reading a portion of them took us over a minute! Dr. Chalasani took time out of her busy day to speak with Ann about the state of breast cancer in 2021. She discussed genetics and environmental...
We asked which type of cancer warranted a deeper dive. You responded with Breast Cancer. And we listened. For women, breast cancer is the most common form of cancer, other than skin melanoma. The odds of developing breast cancer at some point in a woman's...
“I’m sorry, but you have breast cancer.”
I survived stage 3 breast cancer. While being infused with this new, life-saving medication, I often thought, “How did this medication get to me?”
Join us for this special update from Reglagene, the first company in CANCER FUND's portfolio of investments. Reglagene is working to develop targeted cancer therapies, delivered via oral medication, that control cancer cells' ability to become...
Research is only the first step when it comes to cancer innovations. But there are many more stops along the journey from lab to patient. And the catalyst behind it all? Funding, of course! Meet Jon Mengel from CANCER FUND, as he discusses the nearly 150...
May is National Cancer Research Month, during which the American Association for Cancer Research partners with advocacy groups, cancer centers, and research institutions to raise awareness of the high-quality, innovative cancer research. But is it enough?...
As we wrap up our latest series, “Measure Twice, Cut Once: Diagnostics and Monitoring,” let’s take a look back at the four innovators who joined us to share about their innovative technologies.
Stress, cortisol, cancer, and YOU. Meet Jeff Rea of Cormometer, an exciting innovation that puts the patient in the driver seat when it comes to monitoring hormonal stress that can impact cancer treatment and overall wellness....
Over-diagnosis or under-treatment? Dr. Ajay Bhatnagar talks about how diagnostic technologies are moving towards personalization to improve outcomes, and the anticipated wave of late-stage cancers coming as a result of the COVID pandemic....
The most common type of cancer is breast cancer, with 279,100 new cases in the United States in 2020. But there is still so much work to be done to properly diagnosis breast cancer early to save lives and provide less invasive treatments. Jayne Shaw,...
Meet Innovator #2 of our "Diagnostics & Monitoring" series, Joe Camaratta, CEO of Quantitative Radiology Solutions. Joe has pivoted his 30 year background in medical imaging and healthcare IT to focus on bringing ideas out of academia and to market....
Meet biomedical engineer Aaron Weinroth as he discusses SWAN Cytologics and their "elegant solution" to the "inadequacy, inefficiency, and trauma" of traditional needle biopsies. https://youtu.be/gOkNGBP9dak
Meet Michael Moore, CEO & Co-Founder of Pathware. Michael's very personal experiences with cancer and delayed diagnoses fueled his passion to improve the world of medical technology. https://youtu.be/Pj94yvRIsCQ
“I was born in Minneapolis, early, with a birth defect called spina bifida. That really didn’t affect much of my growing up, except for a few surgeries as I was growing, and one immediately following my birth to close the hole in my spine. Other than...
Introducing our newest series, focusing on cancer diagnostics and monitoring. CANCER FUND Chief Medical Officer, Dr. Ajay Bhatnagar, joins us to chat about the current state of cancer diagnostic tools and potential paths forward to improve cancer...
